continuous molecular monitoring

A model wearing the Nutromics lab-on-a-patch continuous monitoring device
By  Adam Ang 02:06 am September 9, 2022
Medtech startup Nutromics has received a $14 million investment from strategic investors, including Dexcom Ventures, VU Venture Partners, and Artesian Investments. Founded in 2017, the company is developing a continuous diagnostic monitoring platform called lab-in-a-patch that uses DNA sensor technology to track multiple targets in the human body, including disease biomarkers and hard-to-dose...
Alt text: A screenshot of the CMM device description in Nutromics's website
By  Adam Ang 04:34 am August 27, 2021
Nutromics, an Australian medical technology startup, has raised A$5.7 million ($4.1 million) in a pre-market funding round participated by private investors. This brings its total capital raised in the past three years to A$10 million ($7.2 million). WHAT IT DOES Founded in 2018, the startup is developing continuous molecular monitoring (CMM) platform technology that is able to track multiple...